Financings
iFabric Corp. Announces Closing of $28 Million Bought Deal Offering
iFabric Closes $28M Bought Deal at a Discount as Revenue Surges 288% on Medical Scrubs and Footwear Boom

Executive Summary
- iFabric Corp. closed a previously announced upsized bought deal treasury and secondary offering on June 5, 2026.
- The company raised $23.0 million in gross proceeds from the treasury portion, while selling shareholders Hylton Karon and Susan Karon raised $5.0 million.
- Total aggregate gross proceeds reached $28.0 million, with the underwriters fully exercising their 15% over-allotment option.
- Issue price was set at $3.70 per share.
- Net proceeds are designated for working capital and general corporate purposes.
- The offering increased the total shares outstanding from approximately 30.3 million to roughly 37.9 million.
Material Impact
- The financing is a routine execution of a previously announced capital raise, but the execution details carry negative weight.
- The $3.70 issue price represents a ~10% discount to the recent trading range ($4.09-$4.99), indicating immediate dilution for existing shareholders.
- The secondary portion of the offering ($5.0 million) was sold by the controlling shareholders (Karon family), reducing their stake from ~63.3% to ~50.0%. While still controlling, insider selling during a price run-up is a negative sentiment signal.
- The capital raise is fundamentally necessary given the company's rapid revenue scaling, but it highlights the cash-intensive nature of the business model.
- The news does not introduce new operational catalysts or strategic shifts; it is purely a balance sheet management event.
IFA · Price
Company Overview
- iFabric Corp. develops and licenses advanced textile technologies, primarily through its subsidiary Intelligent Fabric Technologies (North America) Inc. (IFTNA).
- Flagship Project: The PROTX2® antimicrobial and ecoPEL® durable-water-repellent technologies integrated into medical apparel (scrubs) and footwear.
- Commercial Execution: Successfully scaled clinically validated scrubs programs with major retailers including Walmart (US) and Costco (Canada). Expanded into footwear via a Roots® branded program and intimate apparel via the owned Nudish™ brand following the Maidenform® license expiry.
- Growth Drivers: Rapid expansion of healthcare apparel, category expansion into footwear and bedding, and transition from royalty-bearing licenses to higher-margin owned brands.
More from IFABRIC CORP. J
Jun 30, 2026 · 06:30